Adverse cutaneous reactions to influenza vaccinations and chemotherapy

Cutaneous sıde-effects of the potential COVID-19 drugs

COVID‐19 disease is a highly contagious and particularly popular problem in all countries. A variety of repurposed drugs and investigational drugs such as remdesivir, chloroquine, hydroxychloroquine, ritonavir, lopinavir, interferon‐beta, and other potential drugs have been studied for COVID19 treatment. We reviewed the potential dermatological side‐effects of these drugs.

Coronavirus-days ın dermatology

Severe acute respiratory syndrome‐corona virus‐2, which causes coronavirus disease 2019 (COVID‐19), is highly contagious and a particularly popular problem in all around the World and also in all departments of every hospital. In order to protect the well‐being of health care providers while providing a sufficient workforce to respond to the COVID‐19 are vital for pandemic planning. In this article, we will discuss this problem from a dermatological aspect.

Possible Oseltamivir-Induced Angioedema in a Patient with Chronic Renal Failure

Objective

To report a case of angioedema possibly associated with oseltamivir administration in a patient with chronic renal failure.

Case Summary

A 46-year-old female with an extensive allergy history and multiple co-morbidities, including chronic renal failure, was diagnosed with H1N1 influenza and given prescriptions for oseltamivir and methylprednisolone at an outside emergency department. She was sent home and took the first dose of both medications. The following day, the patient developed tongue swelling and left-sided edema. She discontinued methylprednisolone but continued oseltamivir. Her symptoms continued to worsen with the development of hivelike lesions and significant shortness of breath leading to hospitalization. Upon admission, oseltamivir was discontinued and the patient was started on dialysis. The patient's symptoms gradually improved, and she was discharged on hospital day 8.

Discussion

Oseltamivir was thought to be the causative agent due to the abrupt onset and resolution of symptoms associated with the administration and discontinuation of the medication. Application of the Naranjo probability scale found that oseltamivir was a possible cause of the patient's angioedema.

Conclusion

Health care providers should be aware of the rare but potentially life-threatening angioedema that may be associated with oseltamivir use.

Influenza-Schutzimpfung und Dermatosen - Koinzidenz oder kausale Assoziation? Influenza vaccination and skin disease - coincidence or causal association?

Influenza remains an important cause of morbidity and mortality worldwide; therefore, vaccination of risk groups is recommended by health authorities in many countries of the world. Vaccination against influenza has been implicated occasionally induce or trigger skin diseases. We review the literature and present data from the German registry for vaccination-associated adverse effects at the Paul-Ehrlich-Institut. In addition to local reactions at the injection site, exanthema, urticaria and anaphylactic reactions to vaccine components, vasculitis has been documented to be likely induced or triggered by influenza vaccination. Other skin diseases do not appear to be associated with vaccination to influenza. Overall, the risk of vaccination-associated skin disease is very low and is not a reason to avoid of influenza vaccination.

Rare systemic dermatologic reaction after pneumococcal vaccine administration

This case report describes a rare dermatologic reaction in a patient after administration of pneumococcal vaccine. A 65-year-old man developed an extensive dermatitis with pruritus, urticaria, and petechiae 1 week after receiving an intramuscular injection o the vaccine. The reaction resolved with application of topical steroids and oral diphenhydramine hydrochloride. This case report and others in the literature suggest the importance of recognizing the possibility of cutaneous adverse reactions with vaccines, such as the pneumococcal vaccine, which in general have a good safety profile.